About
What it is and where it shows up.
Bay leaf powder is the finely ground dried leaves of Laurus nobilis, a Mediterranean culinary herb long used to impart a subtle, aromatic, slightly bitter flavour to soups, stews, sauces, and spice blends. It is employed as a natural flavouring and spice ingredient in foods worldwide.
Safety summary
The regulatory and scientific consensus.
Bay leaf powder has a long history of safe use as a culinary spice with no established ADI, and is considered GRAS by the US FDA based on its history of consumption. At culinary doses no significant toxicological concerns have been identified in the general adult population. High-dose supplemental use is not well studied and should be approached with caution, particularly in pregnancy and by individuals on diabetes or anticoagulant medications.
Regulatory landscape
What food-safety regulators have decided.
| Jurisdiction | Status | Note |
|---|---|---|
| FSANZ (Food Standards Australia New Zealand) (Australia) | Approved | Bay leaf and bay leaf powder are permitted as spices and natural flavourings under the Australia New Zealand Food Standards Code. No quantitative limit established for culinary use.source |
| EFSA (European Food Safety Authority) (European Union) | Approved | Bay leaf (Laurus nobilis) is permitted as a flavouring substance in the EU under Regulation (EC) No 1334/2008 on flavourings. No E-number assigned; used as a botanical/spice flavouring without a quantitative maximum limit for typical culinary use.source |
| FSSAI (Food Safety and Standards Authority of India) (India) | Approved | FSSAI has formulated product standards for Laurel (Bay leaf) in both whole and powder form under the Food Safety and Standards (Food Products Standards and Food Additives) Amendment Regulations. Bay leaf is also included in the Spices Board of India list, permitting its use as a spice, processed ingredient, and in nutraceutical formulations.source |
| FDA (Food and Drug Administration) (United States) | Approved | Listed under 21 CFR 182.10 as a natural spice, natural substance, and natural extract/flavour that is Generally Recognized as Safe (GRAS) for use in food. No quantitative limit established for culinary use.source |
Who should approach with care
Whose guidance would steer them away.
Pregnancy — Bay leaf contains volatile compounds (e.g., eugenol, estragole) that at supplemental doses may have uterine-stimulating properties; culinary use is generally considered safe but high-dose supplementation should be avoided during pregnancy.
Diabetes — Clinical evidence (PMID:19168000) shows bay leaf can lower blood glucose, which may potentiate the effect of antidiabetic medications and increase risk of hypoglycaemia when consumed in supplemental quantities.
Liver Disease — Bay leaf contains estragole, a naturally occurring alkenylbenzene that is metabolised hepatically and may pose concern at high supplemental doses in individuals with compromised liver function, in line with EFSA's guidance on botanical preparations containing estragole.
Epilepsy — The essential oil components of bay leaf (notably eugenol and 1,8-cineole) have reported CNS-active properties at elevated doses; individuals with epilepsy consuming concentrated bay leaf extracts or powders in large quantities should exercise caution.
Research citations
The sources behind this verdict.
- 1FDA. Code of Federal Regulations Title 21, Section 182.10 – Spices and other natural seasonings and flavorings. accessdata.fda.gov
- 2FSSAI. Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Functional Foods and Novel Foods) Regulations – Compendium, 2021. fssai.gov.in
- 3FSSAI. Draft Food Safety and Standards (Food Products Standards and Food Additives) Amendment Regulation, 2018 – Standards for Laurel (Bay leaf) Whole and Powder, 2018. archive.fssai.gov.in
- 4PubMed. Laurus nobilis: composition of essential oil and its biological activities, 2012. pubmed.ncbi.nlm.nih.gov
- 5PubMed. Bay leaves improve glucose and lipid profile of people with type 2 diabetes, 2009. pubmed.ncbi.nlm.nih.gov
Independently researched5 citations